2Zhao D;Liu J;Wang W.Epidemiological transition of stroke in China:twenty-one-year observational study from the Sino-MONICA-Beijing Project[J]STROKE,2008(06):1668-1674.
3Larry B;Goldstein;Cheryl D.Guidelines for the Primary Prevention of Stroke:A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association[J]STROKE,2011(02):517-584.
4Liu L.Cardiovascular diseases in China[J]Biochemistry and Cell Biology/Biochimie et Biologie Cellulaire,2007(02):157-163.
5Kjeldsen SE;Julius S;Hedner T.Stroke is more common than myocardial infarction in hypertension:analysis based on 11 major randomized intervention trials[J]Blood Pressure,2001(04):190-192.
6Amarenco P;Bogousslavsky J;Callahan A 3rd.High-dose atorvastatin after stroke or transient ischemic attack[J]the New England Journal of Medicine,2006(06):549-559.
7Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group.Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction:a double-blind randomised trial[J]The Lancet,2010(9753):1658-1669.
8Wald DS;Law M;Morris JK.Homocysteine and cardiovascular disease:evidence on causality from a meta-analysis[J]British Medical Journal,2002(7374):1202.
9Graham IM;Daly LE;Refsum HM.Plasma homocysteine as a risk factor for vascular disease.The European Concerted Action ProjectThe European Concerted Action Project</a>[J].Journal of the American Medical Association,1997(22):1775-1781.
10Towfighi A;Markovic D;Ovbiagele B.Pronounced association of elevatedserumhomocysteinewithstrokeinsubgroupsofindividuals:a nationwidestudy[J]Journal of Neuroscience,2010(1-2):153-157.
